{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:38:27Z","timestamp":1773679107895,"version":"3.50.1"},"reference-count":152,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":2975,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1111\/ajt.12835","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T17:34:06Z","timestamp":1407173646000},"page":"2206-2220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Hepatitis C Virus Infection and Kidney Transplantation in 2014: What\u2019s New?"],"prefix":"10.1016","volume":"14","author":[{"given":"S.","family":"Baid-Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Moradpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Somasundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Muche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.12835_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/474S1a","article-title":"Nature outlook: Hepatitis C","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1111\/ajt.12835_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.565","article-title":"Hepatitis C virus infection in haemodialysis and kidney transplant patients","volume":"18","author":"Baid-Agrawal","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1111\/ajt.12835_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1478-3231.2011.02537.x","article-title":"The global health burden of hepatitis C virus infection","volume":"31","author":"Negro","year":"2011","journal-title":"Liver Int"},{"key":"10.1111\/ajt.12835_bib4","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/hep.26218","article-title":"Chronic hepatitis C virus (HCV) disease burden and cost in the United States","volume":"57","author":"Razavi","year":"2013","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12835_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1542-4758.2012.00761.x","article-title":"Incidence of hepatitis C virus infection in patients on hemodialysis: A systematic review and meta-analysis","volume":"17","author":"Su","year":"2013","journal-title":"Hemodial Int"},{"key":"10.1111\/ajt.12835_bib6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.transproceed.2008.03.031","article-title":"Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: Analysis of german data","volume":"40","author":"Kliem","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12835_bib7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.transproceed.2009.01.074","article-title":"Impact of hepatitis B and C virus infections on kidney transplantation: A single center experience","volume":"41","author":"Santos","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12835_bib8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0b013e3181f92548","article-title":"Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand","volume":"90","author":"Scott","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1542-4758.2011.00662.x","article-title":"High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis","volume":"16","author":"El-Sherif","year":"2012","journal-title":"Hemodial Int"},{"key":"10.1111\/ajt.12835_bib10","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"73","year":"2008","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12835_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/hep.22706","article-title":"Occult hepatitis C: How convincing are the current data?","volume":"49","author":"Welker","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12835_bib12","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1681\/ASN.2008030293","article-title":"Occult hepatitis C virus infection among hemodialysis patients","volume":"19","author":"Barril","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1432-2277.2009.01025.x","article-title":"No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients","volume":"23","author":"Nicot","year":"2009","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12835_bib14","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1111\/ajt.12400","article-title":"Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient","volume":"13","author":"Cruzado","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2014.01.012","article-title":"Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients","volume":"60","author":"Baid-Agrawal","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib16","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.3748\/wjg.v16.i28.3510","article-title":"Accuracy of ultrasound to identify chronic liver disease","volume":"16","author":"Allan","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1111\/ajt.12835_bib17","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1681\/ASN.2010060668","article-title":"Effect of kidney transplantation on outcomes among patients with hepatitis C","volume":"22","author":"Roth","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000333774","article-title":"Selection and management of hepatitis C virus-infected patients for the kidney transplant waiting list","volume":"176","author":"Roth","year":"2012","journal-title":"Contrib Nephrol"},{"key":"10.1111\/ajt.12835_bib19","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1016\/j.transproceed.2005.09.170","article-title":"Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival","volume":"37","author":"Bestard","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12835_bib20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.cgh.2007.07.010","article-title":"Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease","volume":"5","author":"Pawa","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/ajt.12835_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.RVI.0000109403.52762.C4","article-title":"Transjugular liver biopsy in patients with end-stage renal disease","volume":"15","author":"Ahmad","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1111\/ajt.12835_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2010.05.035","article-title":"Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)","volume":"53","author":"Degos","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12072-012-9342-y","article-title":"APASL consensus statements and management algorithms for hepatitis C virus infection","volume":"6","author":"Omata","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1111\/ajt.12835_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1432-2277.2009.00834.x","article-title":"Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis","volume":"22","author":"Alric","year":"2009","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12835_bib25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2215\/CJN.04320510","article-title":"Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients","volume":"6","author":"Liu","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL clinical practice guidelines: Management of hepatitis C virus infection","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib27","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1097\/01.tp.0000183399.85804.02","article-title":"Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus","volume":"80","author":"Varaut","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12835_bib30","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12835_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-6143.2003.00057.x","article-title":"Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance","volume":"3","author":"Cruzado","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib32","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1097\/01.ASN.0000079613.81511.3C","article-title":"Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation","volume":"14","author":"Kamar","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/00007890-199811150-00023","article-title":"Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: Response to interferon-alpha therapy","volume":"66","author":"Toth","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1681\/ASN.V961109","article-title":"Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients","volume":"9","author":"Munoz De Bustillo","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib35","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1600-6143.2005.00918.x","article-title":"Natural history of hepatitis C virus-related liver fibrosis after renal transplantation","volume":"5","author":"Kamar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1086\/315355","article-title":"Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients","volume":"181","author":"Izopet","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/ajt.12835_bib37","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/gast.2002.36610","article-title":"Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection","volume":"123","author":"Alric","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12835_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/17.1.129","article-title":"Severe evolution of chronic hepatitis C in renal transplantation: A case control study","volume":"17","author":"Zylberberg","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12835_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/ctr.12012","article-title":"Time of acquisition of HCV infection in renal transplant recipients: A major prognostic factor for disease progression","volume":"27","author":"Delladetsima","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.12835_bib40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1399-0012.2009.01017.x","article-title":"The acquisition time of infection: A determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients","volume":"23","author":"Toz","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.12835_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000332387","article-title":"Immunosuppression in hepatitis C virus-infected patients after kidney transplantation","volume":"176","author":"Manuel","year":"2012","journal-title":"Contrib Nephrol"},{"key":"10.1111\/ajt.12835_bib42","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.transproceed.2005.03.010","article-title":"Hepatocellular carcinoma in renal transplant patients","volume":"37","author":"Ridruejo","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12835_bib43","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.transproceed.2008.07.092","article-title":"Hepatocellular carcinoma following renal transplantation: Experience in northern Taiwan","volume":"40","author":"Chiang","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12835_bib44","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.transproceed.2008.06.026","article-title":"Hepatocellular carcinoma in renal transplant recipients","volume":"40","author":"Chuang","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12835_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00007890-200007270-00001","article-title":"Renal disease associated with hepatitis C infection after kidney and liver transplantation","volume":"70","author":"Baid","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000332389","article-title":"Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus infection after renal transplantation","volume":"176","author":"Cruzado","year":"2012","journal-title":"Contrib Nephrol"},{"key":"10.1111\/ajt.12835_bib47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000348477","article-title":"Hepatitis C virus-associated glomerulonephritis","volume":"181","author":"Tang","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1111\/ajt.12835_bib48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/infdis\/162.2.569","article-title":"Hepatitis C virus in patients with cryoglobulinemia type II","volume":"162","author":"Pascual","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1111\/ajt.12835_bib49","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","article-title":"Membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"328","author":"Johnson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12835_bib50","first-page":"141","article-title":"Hepatitis C virus associated membranous glomerulonephritis","volume":"44","author":"Stehman-Breen","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1111\/ajt.12835_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-6143.2001.10212.x","article-title":"Hepatitis C virus infection and de novo glomerular lesions in renal allografts","volume":"1","author":"Cruzado","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2215\/CJN.06920711","article-title":"Hepatitis C virus infection and kidney disease: A meta-analysis","volume":"7","author":"Fabrizi","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib53","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ki.2011.192","article-title":"Transplant glomerulopathy: It\u2019s not always about chronic rejection","volume":"80","author":"Haas","year":"2011","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12835_bib54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.ajkd.2012.10.026","article-title":"Advances in the understanding of transplant glomerulopathy","volume":"62","author":"Husain","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.12835_bib55","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/j.1600-6143.2007.01995.x","article-title":"Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies","volume":"7","author":"Wavamunno","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib56","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1600-6143.2005.01050.x","article-title":"Predicting subsequent decline in kidney allograft function from early surveillance biopsies","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib57","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","article-title":"Transplant glomerulopathy: Subclinical incidence and association with alloantibody","volume":"7","author":"Gloor","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib58","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ki.2011.194","article-title":"Overlapping pathways to transplant glomerulopathy: Chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy","volume":"80","author":"Baid-Agrawal","year":"2011","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12835_bib59","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1681\/ASN.V101146","article-title":"Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients","volume":"10","author":"Baid","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib60","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/j.gastro.2009.11.050","article-title":"Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance","volume":"138","author":"Milner","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12835_bib61","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12835_bib62","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.12835_bib63","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1572-0241.2005.40429.x","article-title":"Chronic hepatitis C and type II diabetes mellitus: A prospective cross-sectional study","volume":"100","author":"Zein","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/ajt.12835_bib64","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib65","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1097\/01.ASN.0000145439.48387.BF","article-title":"Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus","volume":"15","author":"Abbott","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib66","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00007890-200109270-00015","article-title":"Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality","volume":"72","author":"Baid","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib67","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0041-1345(02)03060-9","article-title":"Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: Role of hepatitis C infection","volume":"34","author":"Baid","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12835_bib68","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1097\/01.ASN.0000012382.97168.E0","article-title":"Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus","volume":"13","author":"Bloom","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib69","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/j.1600-6143.2005.01040.x","article-title":"Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: Meta-analysis of clinical studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib70","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/01.TP.0000114283.04840.3A","article-title":"Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation","volume":"77","author":"Delgado-Borrego","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib71","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12835_bib72","first-page":"1384","article-title":"Impaired IRS-1\/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes","volume":"38","author":"Aytug","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12835_bib73","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1111\/j.1600-6143.2009.02843.x","article-title":"Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients","volume":"9","author":"Baid-Agrawal","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib74","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11892-013-0370-3","article-title":"Diabetes and infections-hepatitis C: Is there type 2 diabetes excess in hepatitis C infection?","volume":"13","author":"Naing","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1111\/ajt.12835_bib75","doi-asserted-by":"crossref","first-page":"458","DOI":"10.6002\/ect.2012.0063","article-title":"Risk factors and outcomes of new-onset diabetes after transplant: Single-centre experience","volume":"10","author":"Al-Ghareeb","year":"2012","journal-title":"Exp Clin Transplant"},{"key":"10.1111\/ajt.12835_bib76","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ndt\/gfh1020","article-title":"The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure","volume":"19","author":"Morales","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12835_bib77","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1097\/01.ASN.0000145896.16153.43","article-title":"Hepatitis C, acute humoral rejection, and renal allograft survival","volume":"15","author":"Forman","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12835_bib78","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/TP.0b013e318225dbae","article-title":"Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: Data from the RESITRA\/REIPI cohort","volume":"92","author":"Lopez-Medrano","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib79","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1600-6143.2005.01230.x","article-title":"Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss","volume":"6","author":"Moreso","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib80","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00007890-199510000-00007","article-title":"The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation","volume":"60","author":"Pereira","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib81","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/00007890-199612270-00013","article-title":"Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients","volume":"62","author":"Rao","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib82","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ki.1994.29","article-title":"The impact of hepatitis C virus infection on renal allograft recipients","volume":"45","author":"Roth","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12835_bib83","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.2008.580","article-title":"Rates of first infection following kidney transplant in the United States","volume":"75","author":"Snyder","year":"2009","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12835_bib84","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jvh.12148","article-title":"Meta-analysis of observational studies: Hepatitis C and survival after renal transplant","volume":"21","author":"Fabrizi","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1111\/ajt.12835_bib85","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1432-2277.2008.00694.x","article-title":"Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: Experience with kidney transplantation","volume":"21","author":"Torres","year":"2008","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12835_bib86","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","article-title":"Effect of hepatitis C virus infection on the risk of non-Hodgkin\u2019s lymphoma: A meta-analysis of epidemiological studies","volume":"95","author":"Matsuo","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1111\/ajt.12835_bib87","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: A meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/ajt.12835_bib88","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/ajt.12835_bib89","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus","volume":"297","author":"Giordano","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/ajt.12835_bib90","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/ijc.26283","article-title":"Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: Results from the DANVIR cohort study","volume":"130","author":"Omland","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1111\/ajt.12835_bib91","doi-asserted-by":"crossref","first-page":"638185","DOI":"10.1155\/2012\/638185","article-title":"Indolent B-cell lymphomas associated with HCV infection: Clinical and virological features and role of antiviral therapy","volume":"2012","author":"Arcaini","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1111\/ajt.12835_bib92","doi-asserted-by":"crossref","first-page":"807351","DOI":"10.1155\/2012\/807351","article-title":"Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis","volume":"2012","author":"Forghieri","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1111\/ajt.12835_bib93","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2010-06-275818","article-title":"Hepatitis viruses and non-Hodgkin lymphoma: Epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities","volume":"117","author":"Marcucci","year":"2011","journal-title":"Blood"},{"key":"10.1111\/ajt.12835_bib94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib95","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.meg.0000231752.50587.ae","article-title":"Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: Any role for hepatitis C infection?","volume":"18","author":"Burra","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/ajt.12835_bib96","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: Report of 230 cases from the French Registry","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib97","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11255-006-0050-1","article-title":"Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient","volume":"38","author":"Aravindan","year":"2006","journal-title":"Int Urol Nephrol"},{"key":"10.1111\/ajt.12835_bib98","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.transproceed.2009.01.094","article-title":"Trends in kidney transplantation outcome: The Andalusian Kidney Transplant Registry, 1984-2007","volume":"41","author":"Gentil Govantes","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12835_bib99","doi-asserted-by":"crossref","first-page":"c72","DOI":"10.1159\/000089090","article-title":"Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients","volume":"102","author":"Mitwalli","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1111\/ajt.12835_bib100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4318\/tjg.2011.0236","article-title":"The impact of hepatitis C virus infection on long-term outcome in renal transplant patients","volume":"22","author":"Ruhi","year":"2011","journal-title":"Turk J Gastroenterol"},{"key":"10.1111\/ajt.12835_bib101","first-page":"247","article-title":"The impact of hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies: The impact of HCV on renal transplantation","volume":"11","author":"Rostami","year":"2011","journal-title":"Hepat Mon"},{"key":"10.1111\/ajt.12835_bib102","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/TP.0b013e31826fc98f","article-title":"Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients","volume":"94","author":"Gentil Govantes","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib103","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/TP.0b013e3182848de2","article-title":"Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: A systematic review and meta-analysis","volume":"95","author":"Ingsathit","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib104","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4103\/1319-2442.113847","article-title":"Outcomes following renal transplantation in patients with chronic hepatitis C based on severity of fibrosis on pre-transplant liver biopsy","volume":"24","author":"Dbouk","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1111\/ajt.12835_bib105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri3463","article-title":"25 years of interferon-based treatment of chronic hepatitis C: An epoch coming to an end","volume":"13","author":"Heim","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/ajt.12835_bib106","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2013.04.035","article-title":"Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)\u2014NCT01514890","volume":"59","author":"Hezode","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib107","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/emmm.201303131","article-title":"Emerging therapies for the treatment of hepatitis C","volume":"6","author":"Lange","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1111\/ajt.12835_bib108","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMra1213651","article-title":"Current and future therapies for hepatitis C virus infection","volume":"368","author":"Liang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12835_bib109","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","article-title":"Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options","volume":"368","author":"Jacobson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12835_bib110","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12835_bib111","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-6143.2003.30113.x","article-title":"Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy","volume":"3","author":"Baid","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib112","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1365-2036.2006.03151.x","article-title":"Meta-analysis: Anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/ajt.12835_bib113","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/ndt\/gfm678","article-title":"Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts","volume":"23","author":"Weclawiack","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12835_bib114","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1365-2036.2003.01780.x","article-title":"Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients","volume":"18","author":"Fabrizi","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/ajt.12835_bib115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/gut.2007.133884","article-title":"Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: A randomised study","volume":"57","author":"Liu","year":"2008","journal-title":"Gut"},{"key":"10.1111\/ajt.12835_bib116","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/655682","article-title":"Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C","volume":"51","author":"Liu","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.12835_bib117","first-page":"181","article-title":"Meta-analysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection","volume":"4","author":"Alavian","year":"2010","journal-title":"Iran J Kidney Dis"},{"key":"10.1111\/ajt.12835_bib118","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jmv.21542","article-title":"Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials","volume":"82","author":"Fabrizi","year":"2010","journal-title":"J Med Virol"},{"key":"10.1111\/ajt.12835_bib119","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.23985","article-title":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models","volume":"53","author":"Thomas","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12835_bib120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1525-139X.2011.00851.x","article-title":"Should ribavirin be used to treat hepatitis C in dialysis patients?","volume":"24","author":"Carrion","year":"2011","journal-title":"Semin Dial"},{"key":"10.1111\/ajt.12835_bib121","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/j.1365-2893.2010.01405.x","article-title":"Combined antiviral therapy of hepatitis C virus in dialysis patients: Meta-analysis of clinical trials","volume":"18","author":"Fabrizi","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1111\/ajt.12835_bib122","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2036.2011.04741.x","article-title":"Anti-viral therapy in haemodialysed HCV patients: Efficacy, tolerance and treatment strategy","volume":"34","author":"Deltenre","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/ajt.12835_bib123","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/0003-4819-159-11-201312030-00005","article-title":"Pegylated interferon-alpha2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial","volume":"159","author":"Liu","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.12835_bib124","unstructured":"AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C. Available at: http:\/\/www.hcvguidelines.org\/. Accessed April 24, 2014."},{"key":"10.1111\/ajt.12835_bib125","unstructured":"EASL. EASL recommendations on treatment of hepatitis C 2014. Available at: http:\/\/www.easl.eu\/_newsroom\/latest-news\/easl-recommendations-on-treatment-of-hepatitis-c-2014. Accessed April 24, 2014."},{"key":"10.1111\/ajt.12835_bib126","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0168-8278(13)60069-0","article-title":"Telaprevir with adjusted dose of ribavirin in na\u00efve CHC-G1: Efficacy and treatment in CHC in hemodialysis population. TARGET C (RCT)","volume":"58","author":"Basu","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib127","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcv.2012.10.009","article-title":"Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: Is it feasible?","volume":"56","author":"Dumortier","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1111\/ajt.12835_bib128","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1016\/S0168-8278(13)60902-2","article-title":"Telapprevir or boceprevir therapy in chronic hepatitis C patients with end stage renal disease on hemodialysis is safe, tolerable and feasible","volume":"58","author":"Sclair","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib129","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1016\/S0168-8278(12)61113-1","article-title":"The effect of renal impairment and end stage renal disease on the single-dose pharmacokinetics of GS-7977","volume":"56","author":"Cornpropst","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: An update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12835_bib131","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1432-2277.2008.00831.x","article-title":"Pegylated interferon-alpha-based treatment for chronic hepatitis C in renal transplant recipients: An open pilot study","volume":"22","author":"Pageaux","year":"2009","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12835_bib132","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3748\/wjg.v18.i1.55","article-title":"Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients","volume":"18","author":"Aljumah","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1111\/ajt.12835_bib133","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jhep.2013.02.004","article-title":"Safety and efficacy of peginterferon-alpha2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C","volume":"58","author":"Sanai","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib134","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2004-832926","article-title":"Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD)","volume":"24","author":"Reddy","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1111\/ajt.12835_bib135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jmv.23919","article-title":"Treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies","volume":"86","author":"Fabrizi","year":"2014","journal-title":"J Med Virol"},{"key":"10.1111\/ajt.12835_bib136","doi-asserted-by":"crossref","first-page":"e90611","DOI":"10.1371\/journal.pone.0090611","article-title":"Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: An updated meta-analysis","volume":"9","author":"Wei","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/ajt.12835_bib137","unstructured":"Jacobson I, Ghalib R, Rodriguez-Torres M, et al. SVR results of a once-daily regimen of simeprevir (TMC435) plus sofosbuvir (GS-7977) with or without ribavirin in cirrhotic and non-cirrhotic HCV genotype 1 treatment-na\u00efve and prior null responder patients: The COSMOS study. Hepatology 2013; 58(Meeting Abstract #LB3): 1379A\u20131380A."},{"key":"10.1111\/ajt.12835_bib138","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jhep.2013.11.013","article-title":"Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting","volume":"60","author":"Tischer","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12835_bib139","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/ajt.12209","article-title":"Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C","volume":"13","author":"Fontana","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib140","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK)","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib141","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: Current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib142","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/TP.0b013e318255f890","article-title":"Kidney transplantation alone in ESRD patients with hepatitis C cirrhosis","volume":"94","author":"Paramesh","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib143","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/lt.23440","article-title":"Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: An analysis of the united network for organ sharing database","volume":"18","author":"Martin","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12835_bib144","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.transproceed.2010.04.056","article-title":"Kidney grafts from HCV-positive donors: Advantages and disadvantages","volume":"42","author":"Maluf","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12835_bib145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2012.03.015","article-title":"Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients","volume":"60","author":"Kucirka","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.12835_bib146","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/00007890-199812270-00021","article-title":"Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation","volume":"66","author":"Ali","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12835_bib147","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2010.03280.x","article-title":"Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients","volume":"10","author":"Morales","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib148","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1399-0012.2011.01583.x","article-title":"The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience","volume":"26","author":"Singh","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.12835_bib149","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000332392","article-title":"Renal transplantation from donors with a positive serology for hepatitis C","volume":"176","author":"Dominguez-Gil","year":"2012","journal-title":"Contrib Nephrol"},{"key":"10.1111\/ajt.12835_bib150","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients","volume":"4","author":"Abbott","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib151","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","article-title":"Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients","volume":"10","author":"Kucirka","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12835_bib152","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1034\/j.1399-0012.2000.14040602.x","article-title":"Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors","volume":"14","author":"Mandal","year":"2000","journal-title":"Clin Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12835","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522256184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522256184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:06:38Z","timestamp":1761627998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522256184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":152,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1600613522256184"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12835","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C Virus Infection and Kidney Transplantation in 2014: What\u2019s New?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}